LUNGevity Foundation is pleased to offer five lung cancer translational research award programs in 2021:

  • LUNGevity’s Career Development Award Program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas. Research that will be funded in 2021 is expected to have a direct impact on the early detection of lung cancer and/or individualized lung cancer treatment, including through targeted therapy and immunotherapy.
    Learn more

 

  • LUNGevity’s Early Detection Award Program supports the development of strategies for the early detection and/or diagnosis of lung cancer. Research that will be funded in 2021 is expected to have a direct impact on the early detection and/or diagnosis of lung cancer or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or diagnosis of lung cancer.
    Learn more

 

  • LUNGevity’s Veterans Affairs Research Scholar Award Program supports fellows or junior faculty interested in lung cancer research within the Department of Veterans Affairs. Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment. In addition, the proposed research must have relevance to the veteran population, related to either screening/early detection of lung cancer or treatment. This is a mentored award.
    Learn more

 

  • LUNGevity’s Health Equity and Inclusiveness Junior Investigator Award Program supports physician-scientists interested in conducting lung cancer clinical research and bridging health disparities by engaging underserved communities or underrepresented minorities. Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment.
    Learn more

 

  • LUNGevity’s Health Equity and Inclusiveness Research Fellow Award Program supports fellows interested in translational lung cancer research who belong to underrepresented minorities in STEM. Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment. This is a mentored award.
    Learn more

 

  • RETpositive / LUNGevity Award supports project(s) expected to have a direct impact on the outcomes of patients with advanced RET-positive lung cancer, but innovative proposals that address other unmet needs in the RET-positive lung cancer space are also invited for submission. Projects are to include at least one aim that is translational and must be directly related to improvement of patient outcomes and/or lead to a clinical trial. Projects using multikinase inhibitors will not be favorably reviewed.
    Learn more

 

  • The Hamoui Foundation/LUNGevity Award supports high-impact research that seeks to transform the future for people diagnosed with RET-positive lung cancer by changing RET-positive lung cancer into a chronic or curable condition. The goal of the award is to fund impactful proposals in the RET-positive lung cancer space with direct clinical implications within 1-2 years. Projects must be directly related to improvement of patient outcomes and ideally lead to a clinical trial (if the project itself does not include a clinical trial).
    Learn more